Palumbo Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Buy
1,196
+97
+9% +$99.1K 0.3% 57
2026
Q1
$1.01M Buy
1,099
+62
+6% +$62.9K 0.25% 70
2025
Q4
$1.11M Buy
1,037
+2
+0.2% +$1.91K 0.28% 71
2025
Q3
$596K Buy
1,035
+42
+4% +$31.3K 0.19% 80
2025
Q2
$774K Buy
993
+496
+100% +$385K 0.24% 74
2025
Q1
$411K Buy
+497
New +$414K 0.14% 106

Other funds holding LLY

Palumbo Wealth Management's LLY Position: Q2 2026 in Review

Palumbo Wealth Management increased its Eli Lilly (LLY) stake by 8.8% in Q2 2026, buying an estimated $99.1K and bringing the position to 1,196 shares worth $1.43M. The position accounts for 0.3% of the portfolio, ranked #57.

Palumbo Wealth Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Palumbo Wealth Management held 1,196 shares of Eli Lilly worth $1.43M as of Q2 2026.
  • Palumbo Wealth Management bought 97 Eli Lilly shares in Q2 2026, an estimated $99.1K.
  • Eli Lilly made up 0.3% of Palumbo Wealth Management's portfolio in Q2 2026, its #57 holding.
  • Palumbo Wealth Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.